Vertebral Fracture and Osteonecrosis Associated With High-dose Glucocorticoid

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
Osteoporotic vertebral fracture (VF) and osteonecrosis of the femoral head (OFH) are major concerns in patients with systemic rheumatic diseases treated with high-dose glucocorticoids (GCs). The investigators examined and compared the incidence and risk factors of VF with those of OFH in patients who had recently received high-dose GC therapy to clarify the relationship between these two complications.
Epistemonikos ID: 061fcfd92b81f3117cc5eb56835b1490f3ca6784
First added on: May 05, 2024